A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4
about
Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells.Oncolytic Immunotherapy for Treatment of Cancer.Transcriptional retargeting of herpes simplex virus for cell-specific replication to control cancer.Detection of circulating tumor cells using oHSV1-hTERT-GFP in lung cancer.Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.
P2860
A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@ast
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@en
type
label
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@ast
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@en
prefLabel
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@ast
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@en
P2093
P2860
P356
P1433
P1476
A novel oHSV-1 targeting telom ...... ulating the expression of ICP4
@en
P2093
Binlei Liu
Lingling Liu
Shuren Zhang
Xiufen Zhuang
Youhui Zhang
P2860
P304
20345-20355
P356
10.18632/ONCOTARGET.3884
P407
P577
2015-05-06T00:00:00Z